Search in:

Advanced search

Clinical Epidemiology Volume 11, 2019 - Issue

Submit an article Journal homepage

Open access

141

Views

CrossRef citations to date

Altmetric

Original Research

Serum 25-hydroxyvitamin D levels predict cancer survival: a prospective cohort with measurements prior to and at the time of cancer diagnosis

Trude Eid Robsahm1 The Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, NorwayCorrespondence[email protected]

https://orcid.org/0000-0002-1652-7734

Steinar Tretli1 The Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway

Peter Abusdal Torjesen2 The Hormone Laboratory, Department of Endocrinology, Oslo University Hospital Health Authority, Oslo, Norway

Ronnie Babigumira1 The Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway

Gary G Schwartz3 Department of Population Health, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND, USA

Pages 695-705 | Published online: 08 Aug 2019

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

Bikle D Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009;94:26–34. doi:10.1210/jc.2008-145418854395
PubMed Web of Science ®Google Scholar
Yin L, Ordonez-Mena JM, Chen T, Schöttker B, Arndt V, Brenner H Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: A systematic review and meta-analysis. Prev Med. 2013;57:753−64. doi:10.1016/j.ypmed.2013.08.02624036014
PubMed Web of Science ®Google Scholar
Cashman KD, van den Heuvel EGHM, Schoemaker RJW, Preveraud DP, Macdonald HM, Arcot J 25-hydroxyvitamin D as a biomarker of vitamin D status and its modeling to inform strategies for prevention of vitamin D deficiency within the population. Sdv Nutr. 2017;8:947−57.
PubMed Web of Science ®Google Scholar
Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev. 1998;7(5):391–395.9610788
PubMed Web of Science ®Google Scholar
Barreto A, Schwartz GG, Woodruff R, Cramer SD 25-hydroxyvitamin D3, the prohormonal form of 1,25-Dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiol Biomarkers Prev. 2000;9:265−270.10750664
PubMed Web of Science ®Google Scholar
Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. Clin Cancer Res. 2000;6:901−8.10741714
PubMed Web of Science ®Google Scholar
Swami S, Krishnan AV, Wang JY, et al. Dietary vitamin D3 and 1,25-dihydroxyvitamin D3 (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer. Endocrinolology. 2012;153:2576−87. doi:10.1210/en.2011-1600
PubMed Web of Science ®Google Scholar
Merchan BB, Morcillo S, Martin-Nunez G, Tinahones FJ, Marcias-Gonzalez M The role of vitamin D and VDR in carcinogenesis: through epidemiology and basic science. J Steroid Biochem Mol Biol. 2017;167:203−18.27913313
PubMed Web of Science ®Google Scholar
Li M, Chen P, Li J, Chu R, Xie D, Wang H Review: the impact of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014;99:2327−36. doi:10.1210/jc.2013-432024780061
PubMed Web of Science ®Google Scholar
Vaughan-Shaw PG, O’Sullivan F, Farrington SM, et al. The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis. Brit J Cancer. 2017;116:1092−1110. doi:10.1038/bjc.2017.4428301870
PubMed Web of Science ®Google Scholar
Robsahm TE, Schwartz GG, Tretli S The inverse relationship between 25-hydroxyvitamin D and cancer survival: discussion of causation. Cancers (Basel). 2013;5(4):1439−55. doi:10.3390/cancers504143924202453
PubMedGoogle Scholar
Tretli S, Hernes E, Berg JP, Hestvik UE, Robsahm TE Association between serum 25(OH)D and death from prostate cancer. Brit J Cancer. 2009;100:450−54. doi:10.1038/sj.bjc.660486519156140
PubMed Web of Science ®Google Scholar
Tretli S, Schwartz GG, Torjesen PA, Robsahm TE Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control. 2012;23:363−70. doi:10.1007/s10552-011-9885-622193397
PubMed Web of Science ®Google Scholar
Langseth H, Gislefoss RE, Martinsen JI, Dillner J, Ursin G Cohort profile: the janus serum bank cohort in Norway. Int J Epidemiol. 2017;46(2):403−404g. doi:10.1093/ije/dyw31727063606
PubMed Web of Science ®Google Scholar
Larsen IK, Smastuen M, Johannesen TB, et al. Data quality at the cancer registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009;45(7):1218−31. doi:10.1016/j.ejca.2008.10.03719091545
PubMed Web of Science ®Google Scholar
Aalerud TN, Johnsen BJ The Norwegian UV monitoring network. Period 1995/96 to 2004. Report 2006: 4. Østerås: Norwegian Radiation Protection Authority; 2006.
Google Scholar
Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010;467:1114−17. doi:10.1038/nature0951520981102
PubMed Web of Science ®Google Scholar
Cancer Registry of Norway. Cancer in Norway 2017 – Cancer Incidence, Mortality, Survival and Prevalence in Norway. Oslo: Cancer Registry of Norway, 2018.
Google Scholar
Weinstein SJ, Mondul AM, Yu K, et al. Circulating 25-hydroxyvitamin D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival. Eur J Epidemiol. 2018 [Epub ahead of print]. doi:10.1007/s10654-018-0428-2
Web of Science ®Google Scholar
Chowdhury R, Kunutsor S, Vitezova A, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 2014;348:g1903. doi:10.1136/bmj.g190324690623
PubMed Web of Science ®Google Scholar
Schöttker B, Jorde R, Peasey A, et al. Consortium on health and ageing: network of cohorts in Europe and the United States. Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ. 2014;348:g3656. doi:10.1136/bmj.g365624938302
PubMed Web of Science ®Google Scholar
Gaksch M, Jorde R, Grimnes G, et al. Vitamin D and mortality: individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PLoS One. 2017;12(2):e0170791. doi:10.1371/journal.pone.017079128207791
PubMed Web of Science ®Google Scholar
Afzal S, Brøndum-Jacobsen P, Bojesen SE, Nordestgaard BG Genetically low vitamin D concentrations and increased mortality: mendelian randomisation analysis in three large cohorts. BMJ. 2014;349:g6330. doi:10.1136/bmj.g633025406188
PubMed Web of Science ®Google Scholar
Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988–2006). Cancer Res. 2010;70:8587−97. doi:10.1158/0008-5472.CAN-10-142020847342
PubMed Web of Science ®Google Scholar
Mousavi SE, Amini H, Heydarpour P, Chermahini FA, Godderis L Air pollution, environmental chemicals, and smoking may trigger vitamin D deficiency: evidence and potential mechanisms. Environ Int. 2018;122:67−90. pii: S0160-4120(18)32126-3.
Web of Science ®Google Scholar
Schöttker B, Hagen L, Zhang Y, et al. Serum 25-hydroxyvitamin D levels as an ageing marker. Strong associations with age and all-cause mortality independent from telomere length, epigenetic age acceleration and 8-isoprostane levels. J Gerontol A Biol Sci Med Sci. 2018;74(1):121−128.
Web of Science ®Google Scholar
Fedirko V, Riboli E, Tjønneland A, et al. Pre-diagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in Western European populations. Cancer Epidemiol Biomarkers Prev. 2012;21(4):582−9. doi:10.1158/1055-9965.EPI-11-106522278364
PubMed Web of Science ®Google Scholar
Verone-Boyle AR, Shoemaker S, Attwood K, et al. Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo. Oncotarget. 2016;7(1):995–1013. doi:10.18632/oncotarget.649326654942
PubMedGoogle Scholar
Kim SJ, Shu C, Ryu KJ, et al. Vitamin D deficiency is associated with inferior survival of patients with extranodal natural killer/T-cell lymphoma. Cancer Sci. 2018 [Epub ahead of print]. doi:10.1111/cas.13844
Web of Science ®Google Scholar
Bochen F, Balensiefer B, Körner S, et al. Vitamin D deficiency in head and neck cancer patients - prevalence, prognostic value and impact on immune function. Oncoimmunology. 2018;7(9):e1476817. doi:10.1080/2162402X.2018.149085430228945
PubMed Web of Science ®Google Scholar
Griffin N, Dowling M Vitamin D supplementation and clinical outcomes in cancer surviovorship. Br J Nurs. 2018;27(19):1121–1128. doi:10.12968/bjon.2018.27.19.112130346823
PubMedGoogle Scholar
Hjerkind KV, Gislefoss RE, Tretli S, et al. Cohort profile update: the janus serum bank cohort in Norway. Int J Epidemiol. 2017;46(4):1101−1102f. doi:10.1093/ije/dyw31728087783
PubMed Web of Science ®Google Scholar
Agborsangaya C, Toriola AT, Grankvist K, et al. The effects of storage time and sampling season on the stability of serum 25-hydroxy vitamin D and androstenedione. Nutr Cancer. 2010;62(1):51−7.20043259
PubMed Web of Science ®Google Scholar

References

The National Advice Board for Nutrition. [Vitamin D in Norway]. Helsedirektoratet, IS 2772, Oslo, Norway: Helsedirektoratet; 2018 Available from: https://www.helsedirektoratet.no/search?searchquery=vitamin+D+i+befolkningen&type=helsedirektoratet%3Arapport.Norwegian. Norwegian.
Google Scholar
Fürst medical laboratory. Available from: http://www.furst.no/analyse-og-klinikk/analyser/vitamin-d/. Accessed May 6, 2019. Norwegian.
Google Scholar
Carlberg C. Moving averages and centered moving averages In: More Predictive Analytics: Microsoft Excel, Que; Upper Saddle River: Que (Pearson Education Informit); 2015 Available from: http://www.informit.com/articles/article.aspx?p=2433607&seqNum=2.
Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Serum 25-hydroxyvitamin D levels predict cancer survival: a prospective cohort with measurements prior to and at the time of cancer diagnosis

References

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Serum 25-hydroxyvitamin D levels predict cancer survival: a prospective cohort with measurements prior to and at the time of cancer diagnosis

References

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date